CLUSTER
Gold-Catalyzed Cycloisomerization of Functionalized 1,5-Enynes
79
(9) For asymmetric cycloisomerization of 1,6-enynes, see:
(a) Pradal, A.; Toullec, P. Y.; Michelet, V. Synthesis 2011,
1501. (b) Pradal, A.; Chao, C.-M.; Vitale, M. R.; Toullec, P.
Y.; Michelet, V. Tetrahedron 2011, 67, 4371. (c) Pradal,
A.; Chao, C.-M.; Vitale, M.; Toullec, P. Y.; Michelet, V.
Beilstein J. Org. Chem. 2011, 7, 1021. (d) Andreiadis, E.;
Vitale, M. R.; Mézailles, N.; Le Goff, X.; Le Floch, P.;
Toullec, P. Y.; Michelet, V. Dalton Trans. 2010, 39, 10608.
(e) Chao, C.-M.; Vitale, M.; Toullec, P. Y.; Genêt, J.-P.;
Michelet, V. Chem. Eur. J. 2009, 15, 1319. (f)Chao,C.-M.;
Genin, E.; Toullec, P. Y.; Genêt, J.-P.; Michelet, V.
J. Organomet. Chem. 2009, 694, 538. (g) Chao, C.-M.;
Beltrami, D.; Toullec, P. Y.; Michelet, V. Chem. Commun.
2009, 6988.
(2 H, s), 3.33 (2 H, s), 3.79 (6 H, s), 5.72 (1 H, s), 6.26–6.37
(3 H, m), 7.15–7.31 (5 H, m). 13C NMR (75 MHz, CDCl3):
d = 18.6, 27.1, 30.4, 37.8, 43.0, 45.0, 55.2, 97.9, 106.8,
125.7, 128.0, 128.3, 133.4, 140.3, 141.3, 142.5, 160.8.
Compound 26: 1H NMR (300 MHz, CDCl3): d = 1.75 (3 H,
s), 1.70–1.84 (1 H, m), 2.20–2.28 (1 H, m), 2.50–2.70 (2 H,
m), 2.75–2.80 (1 H, m), 3.74 (3 H, s), 3.79 (3 H, s), 4.72 (1
H, br s), 4.82 (1 H, br s), 5.83–5.85 (1 H, m), 6.25–6.37 (2
H, m), 7.15–7.31 (5 H, m). 13C NMR (75 MHz, CDCl3): d =
22.3, 32.1, 36.6, 42.2, 55.1, 55.2, 97.3, 101.0, 104.8, 112.1,
125.2, 125.8, 126.8, 132.4, 137.6, 141.0, 143.5, 157.5,
158.1, 159.6. MS (CI): m/z = 321 [M + H]+.
3-Benzyl-5-methylbicyclo[3.1.0]hex-2-ene (29)
Colorless oil. 1H NMR (300 MHz, CDCl3): d = 0.09 (1 H, dd,
J = 3.4, 3.3 Hz), 0.67 (1 H, dd, J = 7.3, 3.5 Hz), 1.24 (3 H,
s), 1.41–1.43 (1 H, m), 2.25 (2 H, s), 3.28 (2 H, s), 5.56 (1 H,
br s), 7.12–7.30 (5 H, m). 13C NMR (75 MHz, CDCl3): d =
21.8, 22.6, 24.2, 29.9, 37.6, 43.9, 125.8, 128.2, 128.7, 130.0,
139.0, 142.0. MS (CI): m/z = 184 [M]+.
(10) (a) Chinchilla, R.; Najera, C. Chem. Rev. 2007, 107, 874.
(b) Doucet, H.; Hierso, J.-C. Angew. Chem. Int. Ed. 2007,
46, 834.
(11) Typical Procedure for the Gold-Catalyzed Reactions of
1,5-Enynes
PPh3AuCl (3.3 mg, 0.0066 mmol) and AgSbF6 (2.3 mg,
0.0066 mmol) were added to a flask under argon atmos-
phere. Then, anhyd Et2O (0.44 mL) and 10 (60 mg, 0.22
mmol) were introduced, and the mixture was stirred for 1 h
at r.t. After filtration of the reactant, the solvent was
evaporated under reduced pressure. The residue was purified
by flash chromatography (cyclohexane–EtOAc, 100:1) on
silica gel to give 21 (55 mg, 92% yield) as a colorless oil.
(12) Mézailles, N.; Ricard, L.; Gagosz, F. Org. Lett. 2005, 7,
4133.
3-Benzyl-5-methyl-1-phenylbicyclo[3.1.0]hex-2-ene (31)
Colorless oil. 1H NMR (300 MHz, CDCl3): d = 0.63 (1 H, d,
J = 4.1 Hz), 0.95 (3 H, s), 1.34 (1 H, d, J = 4.1 Hz), 2.40 (2
H, s), 3.39 (2 H, s), 5.67 (1 H, s), 7.18–7.22 (6 H, m), 7.26–
7.31 (4 H, m). 13C NMR (75 MHz, CDCl3): d = 18.6, 27.2,
30.4, 37.4, 43.0, 45.1, 125.7, 125.9, 127.9, 128.3, 128.8,
133.2, 140.0, 140.4, 141.8. MS (CI): m/z = 260 [M]+.
(17) Teles, J. H.; Brode, S.; Chabanas, M. Angew. Chem. Int. Ed.
1998, 37, 1415.
(18) (a) Koh, J. H.; Gagné, M. R. Angew. Chem. Int. Ed. 2004, 43,
3459. (b) Feducia, J. A.; Gagné, M. R. J. Am. Chem. Soc.
2008, 130, 592; and references cited therein.
(13) 2-[(4-Methoxyphenoxy)methyl]-1,3-dimethylcyclohex-3-
enol (23)
1H NMR (400 MHz, CDCl3): d = 1.27 (6 H, m), 1.76–1.75
(4 H, m), 2.50 (1 H, m), 3.77 (3 H, s), 3.94–3.92 (1 H, dd,
J = 5.8, 7.3 Hz), 4.12–4.08 (1 H, dd, J = 3.0, 7.3 Hz), 5.50 (1
H, t, J = 1.2 Hz), 6.87–6.77 (4 H, m). 13C NMR (100 MHz,
CDCl3): d = 22.3, 23.0, 24.8, 33.7, 50.5, 55.8, 68.9, 71.6,
76.8, 77.1, 77.4, 114.7, 115.7, 123.7, 131.6, 152.7, 154.2.
MS (CI): m/z = 245 [M – H2O + H]+, 262 [M – H2O + NH4]+,
263 [M + H]+, 280 [M + NH4]+.
(19) (a) Conia, J. M.; Le Perchec, P. Synthesis 1975, 1.
(b) Kennedy-Smith, J. J.; Staben, S. T.; Toste, F. D. J. Am.
Chem. Soc. 2004, 126, 4526. (c) Staben, S. T.; Kennedy-
Smith, J. J.; Toste, F. D. Angew. Chem. Int. Ed. 2004, 43,
5350. (d) Ochida, A.; Ito, H.; Sawamura, M. J. Am. Chem.
Soc. 2006, 128, 16486. (e) Ito, H.; Makida, Y.; Ochida, A.;
Ohmiya, H.; Sawamura, M. Org. Lett. 2008, 10, 5051.
(20) (a) Amijs, C. H. M.; López-Carrillo, V.; Raducan, M.; Pérez-
Galán, P.; Ferrer, C.; Echavarren, A. M. J. Org. Chem. 2008,
73, 7721. (b) Yao, T.; Zhang, X.; Larock, R. C. J. Am. Chem.
Soc. 2004, 126, 11164. (c) Teng, T.-M.; Lin, M.-S.; Vasu,
D.; Bhunia, S.; Liu, T.-.; Liu, R.-S. Chem. Eur. J. 2010, 16,
4744. (d) For a recent interesting contribution on allylic
alcohols, see: Chiarucci, M.; Locritani, M.; Cera, G.;
Bandini, M. Beilstein J. Org. Chem. 2011, 7, 1198.
(21) Methyl 5-(1,2-dimethylcyclopent-2-en-1-yl)-2-methyl-
4,5-dihydrofuran-3-carboxylate (37)
(14) Buzas, A. K.; Istrate, F. M.; Gagosz, F. Angew. Chem. Int.
Ed. 2007, 46, 1141.
(15) Nevado, C.; Echavarren, A. M. Synthesis 2005, 167; and
references cited therein.
(16) 3-(3,5-Dimethoxybenzyl)-5-methylbicyclo[3.1.0]hex-2-
ene (25) and 1,2-Dihydro-5,7-dimethoxy-2-(2-
methylallyl)naphthalene (24)
Compound 25: 1H NMR (300 MHz, CDCl3): d = 0.09 (1 H,
dd, J = 3.4, 2.4 Hz), 0.67 (1 H, dd, J = 7.2, 3.5 Hz), 1.24 (3
H, s), 1.41–1.44 (1 H, m), 2.25 (2 H, s), 3.22 (2 H, s), 3.78 (6
H, s), 5.60 (1 H, d, J = 1.7 Hz), 6.30 (3 H, s). 13C NMR (75
MHz, CDCl3): d = 21.8, 22.6, 24.1, 29.9, 37.9, 43.8, 55.2,
97.9, 106.8, 130.3, 141.4, 142.6, 160.7.
1H NMR (300 MHz, CDCl3): d = 1.07 (3 H, s), 1.60–1.67 (4
H, m), 1.87 (1 H, m), 2.16 (3 H, s), 2.16–2.25 (2 H, m), 2.65–
2.81 (2 H, m), 3.71 (3 H, s), 4.59 (1 H, t, J = 10.2 Hz), 5.40
(1 H, br s). 13C NMR (75 MHz, CDCl3): d = 12.9, 14.1, 21.5,
29.0, 31.7, 32.3, 50.6, 53.1, 86.6, 101.9, 126.1, 143.2, 166.7,
168.7. MS (CI): m/z = 237 [M + H]+.
Compound 24: 1H NMR (300 MHz, CDCl3): d = 1.73 (3 H,
s), 1.70–1.84 (1 H, m), 2.10–2.15 (1 H, m), 2.50–2.70 (2 H,
m), 2.75–2.80 (1 H, m), 3.80 (6 H, s), 4.72 (1 H, br s), 4.82
(1 H, br s), 5.75–5.85 (1 H, m), 6.30–6.36 (2 H, m), 6.70–
6.77 (1 H, m). 13C NMR (75 MHz, CDCl3): d = 22.2, 31.3,
34.4, 42.5, 55.0, 55.5, 96.3, 105.1, 112.1, 115.6, 120.6,
129.4, 137.5, 143.5, 156.0, 159.0. MS (CI): m/z = 245 [M +
H]+.
1,2-(Dimethylcyclopent-2-en-1-yl)-2-phenyl-4,5-
dihydrofuran-3-yl)(phenyl)methanone (38)
1H NMR (300 MHz, CDCl3): d = 1.17 (3 H, s), 1.67 (1 H, m),
1.74 (3 H, s), 2.04 (1 H, m), 2.23–2.27 (2 H, m), 3.19, 3.14
(2 H, 2 dd, J = 15.0, 10.3 Hz), 4.83 (1 H, t, J = 10.3 Hz), 5.43
(1 H, br s), 6.99–7.20 (8 H, m), 7.39 (2 H, dd, J = 1.4, 8.4
Hz). 13C NMR (75MHz, CDCl3): d = 13.3, 21.6, 29.1, 33.0,
34.8, 53.2, 86.8, 112.7, 126.3, 127.5, 127.6, 128.8, 129.3,
129.8, 130.3, 130.9, 139.3, 143.2, 166.7, 193.7. MS (CI):
m/z = 345 [M + H]+.
3-(3,5-Dimethoxybenzyl)-5-methyl-1-phenylbicyclo-
[3.1.0]hex-2-ene(27) and 1,2-Dihydro-5,7-dimethoxy-2-
(2-methylallyl)-4-phenylnaphthalene (26)
Compound 27: 1H NMR (300 MHz, CDCl3): d = 0.64 (1 H,
d, J = 4.1 Hz), 0.96 (3 H, s), 1.35 (1 H, d, J = 4.1 Hz), 2.40
© Thieme Stuttgart · New York
Synlett 2012, 23, 74–79